Session date: 
12/08/2022 - 12:00pm to 1:00pm

PRESENTATION TITLE

Targeting 5-HT2B receptor for Cardiopulmonary Disease 

 
PRESENTER(S)
W. David Merryman, Ph.D.
Professor and Associate Chair of Biomedical Engineering, Vanderbilt University 
 
VIEWING LOCATION
Zoom
 
LEARNING OBJECTIVES
  • Examine the mechanisms of 5-HT2B receptor inhibition that prevent disease 
  • Demonstrate that novel 5-HT2B antagonists can be systemically restricted 
  • Validate 5-HT2B antagonism can prevent pulmonary arterial hypertension

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenter: 
W. David Merryman, Ph.D.
Where did the idea for the course originate?: 
Arizona
Please login or register to take this course.
Where did the idea for the course originate?: 
Arizona